你即將離開本站

並前往https://clinicaltrials.gov/ct2/show/NCT02846545

A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes

A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes (T1GER) · Experimental: Group 1: Golimumab. Participants will receive subcutaneous (SC) golimumab ...

確定！ 回上一頁

查詢 「T1ger」的人也找了：

  1. T1ger
    2.
  2. T1ger car dealer
    3.
  3. Esx_knatusrobberybank
    4.
  4. Mhacking
    5.
  5. Loaf housing
    6.
  6. Esx_supermarket
    7.
  7. Esx_shop
    8.
  8. Esx_advancedvehicleshop
    9.